ESMO Deep Dive: Upper Digestive Cancers - Hepatocellular Carcinoma: from Molecule to Medicine

It is with great pleasure that we invite you to participate in the ESMO Deep Dive Webinar in hepatocellular carcinoma (HCC), elaborating the facts from understanding the molecular pathway to drug development and application.

This webinar is developed with the aim to inform on state-of-the-art strategies for treatment of patients with intermediate-stage HCC, to provide insights on optimal options for first-line systemic and locoregional treatment, and to highlight ongoing research in second line and beyond systemic treatment for HCC.

We will begin with a lecture on the changing paradigm of treating patients with intermediate-stage HCC. This will follow with elaboration of first-line treatment options. Finally, we will provide insights in second line and beyond systemic treatment for patients with HCC. The lectures will be followed by a live discussion with the full speakers’ panel.

The programme is designed to provide an overview of rapid progress in incorporating molecular targeting therapies and immune checkpoint inhibitors in the management of patients with HCC, offer expert opinion exchange and provide some important considerations. We strongly encourage and invite you to register and join us all in this new ESMO activity.

Prof. Ann-Lii Cheng
National Taiwan University, Taipei, Taiwan

AND

Prof. Arndt Vogel
Hannover Medical School (MHH), Hannover, Germany